Cingir Koker S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.

Cingir Koker S, Jahja E, Shehwana H, Keskus AG, Konu O. Cingir Koker S, et al. PLoS One. 2018 Dec 13;13(12):e0208982. doi: 10.1371/journal.pone.0208982. eCollection 2018. PLoS One. 2018. PMID: 30543688 Free PMC article.

CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.

Shehwana H, Keskus AG, Ozdemir SE, Acikgöz AA, Biyik-Sit R, Cagnan I, Gunes D, Jahja E, Cingir-Koker S, Olmezer G, Sucularli C, Konu O. Shehwana H, et al. Among authors: cingir koker s. Cell Oncol (Dordr). 2021 Apr;44(2):453-472. doi: 10.1007/s13402-020-00581-x. Epub 2021 Jan 19. Cell Oncol (Dordr). 2021. PMID: 33469842

Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.

Cingir Koker S, Yalcin B, Dogan Turacli I. Cingir Koker S, et al. Mol Biol Rep. 2022 Jul;49(7):5973-5984. doi: 10.1007/s11033-022-07381-6. Epub 2022 Mar 30. Mol Biol Rep. 2022. PMID: 35355210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters